NASDAQ-GM · traded in Congress
Tandem Diabetes Care, TNDM
$16.37 -0.54 (-3.19%) Nov 9, 2026 4:30 AM ET
Market value$1.1B
P/E ratio-
Analyst target$25.50
52-week range-
Avg volume2,098,957
Dividend yieldN/A
Chart
Analyst ratings
- 13 buy
- 12 hold
- 0 sell
Low target$18.00
Average target$27.75
High target$50.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $284M | $160M | $-7M | -2.5% | |
| $255M | $145M | $-21M | -8.3% | |
| $247M | $137M | $-20M | -8.3% | |
| $290M | $167M | $-1M | -0.2% |
Congress trades in TNDM
Members of Congress disclosed 2 transactions in TNDM in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/29/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 10/12/2026 filing |
| 03/03/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
